Case File
efta-02566493DOJ Data Set 11OtherEFTA02566493
Date
Unknown
Source
DOJ Data Set 11
Reference
efta-02566493
Pages
2
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
Sent:
To:
Subject:
Jeffrey Epstein <[email protected]>
Thursday, February 14, 2013 7:29 PM
ok, do you want me to buy your ticket ? would you like to stay the we=kend after , though there will be no meeetins
On Thu, Feb 14, 2013 at 3:16 PM,
Jeffrey,<=div>
Apologies for my late reply.
wrote:
<=iv> I will be able to come on 27th February, basically not possible to=make it earlier, but I will stay until 2-3
March. In any way, it would be = great chance to meet potential private and institutional investors, L/S=equity
managers, etc.
As per your request about my role in BCM, I am respon=ible for managing communication with shareholders,
analysts, building re=ationships with existing and potential private and institutional investors=in the fund. I am also
participating in the investors roundtable cap-intro=events, presenting the BCM to investors one-on-one. On the daily
basis, I =m responding to clients' enquiries concerning performance of the fund =nd general market conditions.
From the organisational perspective, I am also working =n weekly and monthly newsletters of the fund,
presenting quarterly resul=s, and, finally, assisting Dr. Chris in gathering the market data, etc. =/div>
Well, this is what I do.
Looking forward t= hearing from you.
Regards,
Vaiva
Sent from my iPhone
On 14 Feb 2013, at 16:54, Jeffrey =pstein <[email protected] <mailto:[email protected]> wrote:
??
The i=formation contained in this communication is
confidential, may be attor=ey-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unau=horized use, disclosure or copying of this
EFTA_R1_01731717
EFTA02566493
communication or any part th=reof is strictly prohibited
and may be unlawful. If you have received t=is
communication in error, please notify us immediately by
return e-mail or=by e-mail to [email protected] <mailto:[email protected]>, and
destroy this communication and all copies t=ereof,
including all attachments. copyright -all rights reserved
The inform=tion contained in this communication is
confidential, may be attorney-c=ient privileged, may
constitute inside information, and is intended only for
the use of the a=dressee. It is the property of
Jeffrey Epstein
Unauthorized use, di=closure or copying of this
communication or any part thereof is strictl= prohibited
and may be unlawful. If you have received this
communication in error, p=ease notify us immediately by
return e-mail or by e-mail to [email protected], =nd
destroy this communication and all copies thereof,
including all attachm=nts. copyright -all rights reserved
2
EFTA_R1_01731718
EFTA02566494
Technical Artifacts (5)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.